Report for Chiamvimonvat N

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (10)

Title : The Critical Roles of Proteostasis and Endoplasmic Reticulum Stress in Atrial Fibrillation - Sirish_2021_Front.Physiol_12_793171
Author(s) : Sirish P , Diloretto DA , Thai PN , Chiamvimonvat N
Ref : Front Physiol , 12 :793171 , 2021
Abstract : Sirish_2021_Front.Physiol_12_793171
ESTHER : Sirish_2021_Front.Physiol_12_793171
PubMedSearch : Sirish_2021_Front.Physiol_12_793171
PubMedID: 35058801

Title : Suppression of inflammation and fibrosis using soluble epoxide hydrolase inhibitors enhances cardiac stem cell-based therapy - Sirish_2020_Stem.Cells.Transl.Med_9_1570
Author(s) : Sirish P , Thai PN , Lee JH , Yang J , Zhang XD , Ren L , Li N , Timofeyev V , Lee KSS , Nader CE , Rowland DJ , Yechikov S , Ganaga S , Young N , Lieu DK , Yamoah EN , Hammock BD , Chiamvimonvat N
Ref : Stem Cells Transl Med , 9 :1570 , 2020
Abstract : Sirish_2020_Stem.Cells.Transl.Med_9_1570
ESTHER : Sirish_2020_Stem.Cells.Transl.Med_9_1570
PubMedSearch : Sirish_2020_Stem.Cells.Transl.Med_9_1570
PubMedID: 32790136

Title : Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis - Shen_2015_Atherosclerosis_239_557
Author(s) : Shen L , Peng H , Peng R , Fan Q , Zhao S , Xu D , Morisseau C , Chiamvimonvat N , Hammock BD
Ref : Atherosclerosis , 239 :557 , 2015
Abstract : Shen_2015_Atherosclerosis_239_557
ESTHER : Shen_2015_Atherosclerosis_239_557
PubMedSearch : Shen_2015_Atherosclerosis_239_557
PubMedID: 25733327

Title : Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice - Harris_2015_Toxicol.Appl.Pharmacol_286_102
Author(s) : Harris TR , Bettaieb A , Kodani S , Dong H , Myers R , Chiamvimonvat N , Haj FG , Hammock BD
Ref : Toxicol Appl Pharmacol , 286 :102 , 2015
Abstract : Harris_2015_Toxicol.Appl.Pharmacol_286_102
ESTHER : Harris_2015_Toxicol.Appl.Pharmacol_286_102
PubMedSearch : Harris_2015_Toxicol.Appl.Pharmacol_286_102
PubMedID: 25827057

Title : A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARgamma to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction - Xu_2013_Int.J.Cardiol_167_1298
Author(s) : Xu DY , Davis BB , Wang ZH , Zhao SP , Wasti B , Liu ZL , Li N , Morisseau C , Chiamvimonvat N , Hammock BD
Ref : Int J Cardiol , 167 :1298 , 2013
Abstract : Xu_2013_Int.J.Cardiol_167_1298
ESTHER : Xu_2013_Int.J.Cardiol_167_1298
PubMedSearch : Xu_2013_Int.J.Cardiol_167_1298
PubMedID: 22525341

Title : Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models - Liu_2013_Eur.J.Pharm.Sci_48_619
Author(s) : Liu JY , Lin YP , Qiu H , Morisseau C , Rose TE , Hwang SH , Chiamvimonvat N , Hammock BD
Ref : Eur J Pharm Sci , 48 :619 , 2013
Abstract : Liu_2013_Eur.J.Pharm.Sci_48_619
ESTHER : Liu_2013_Eur.J.Pharm.Sci_48_619
PubMedSearch : Liu_2013_Eur.J.Pharm.Sci_48_619
PubMedID: 23291046

Title : Pharmacological inhibition of soluble epoxide hydrolase provides cardioprotection in hyperglycemic rats - Guglielmino_2012_Am.J.Physiol.Heart.Circ.Physiol_303_H853
Author(s) : Guglielmino K , Jackson K , Harris TR , Vu V , Dong H , Dutrow G , Evans JE , Graham J , Cummings BP , Havel PJ , Chiamvimonvat N , Despa S , Hammock BD , Despa F
Ref : American Journal of Physiology Heart Circ Physiol , 303 :H853 , 2012
Abstract : Guglielmino_2012_Am.J.Physiol.Heart.Circ.Physiol_303_H853
ESTHER : Guglielmino_2012_Am.J.Physiol.Heart.Circ.Physiol_303_H853
PubMedSearch : Guglielmino_2012_Am.J.Physiol.Heart.Circ.Physiol_303_H853
PubMedID: 22865388

Title : Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model - Liu_2010_Biochem.Pharmacol_79_880
Author(s) : Liu JY , Yang J , Inceoglu B , Qiu H , Ulu A , Hwang SH , Chiamvimonvat N , Hammock BD
Ref : Biochemical Pharmacology , 79 :880 , 2010
Abstract : Liu_2010_Biochem.Pharmacol_79_880
ESTHER : Liu_2010_Biochem.Pharmacol_79_880
PubMedSearch : Liu_2010_Biochem.Pharmacol_79_880
PubMedID: 19896470

Title : Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches - Li_2009_J.Mol.Cell.Cardiol_47_835
Author(s) : Li N , Liu JY , Timofeyev V , Qiu H , Hwang SH , Tuteja D , Lu L , Yang J , Mochida H , Low R , Hammock BD , Chiamvimonvat N
Ref : Journal of Molecular & Cellular Cardiology , 47 :835 , 2009
Abstract : Li_2009_J.Mol.Cell.Cardiol_47_835
ESTHER : Li_2009_J.Mol.Cell.Cardiol_47_835
PubMedSearch : Li_2009_J.Mol.Cell.Cardiol_47_835
PubMedID: 19716829

Title : The soluble epoxide hydrolase as a pharmaceutical target for hypertension - Chiamvimonvat_2007_J.Cardiovasc.Pharmacol_50_225
Author(s) : Chiamvimonvat N , Ho CM , Tsai HJ , Hammock BD
Ref : J Cardiovasc Pharmacol , 50 :225 , 2007
Abstract : Chiamvimonvat_2007_J.Cardiovasc.Pharmacol_50_225
ESTHER : Chiamvimonvat_2007_J.Cardiovasc.Pharmacol_50_225
PubMedSearch : Chiamvimonvat_2007_J.Cardiovasc.Pharmacol_50_225
PubMedID: 17878749